Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.48 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
| ▸ | PRCP | P42785 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4757414 | 0.83 | HDAC8 (0.47) | HDAC8CACNA1GSLC22A1PRCP | |
| SCHEMBL8181399 | 0.83 | CACNA1G (0.44) | HDAC8CACNA1GMAPT | |
| SCHEMBL8185559 | 0.79 | HTR1A (0.46) | MAPTALDH1A1 | |
| SCHEMBL9142562 | 0.76 | CYP3A4 (0.49) | HDAC8CACNA1GCYP3A4CYP2C19CYP2D6 | |
| SCHEMBL20977566 | 0.76 | CACNA1G (0.39) | HDAC8CACNA1GMAPT | |
| SCHEMBL5218486 | 0.75 | CACNA1G (0.41) | CACNA1GCYP3A4CYP2C19CYP2D6MAPT | |
| SCHEMBL20977455 | 0.75 | CACNA1G (0.43) | CACNA1G | |
| SCHEMBL13446662 | 0.73 | CACNA1G (0.56) | HDAC8CACNA1GCYP3A4CYP2C19CYP2D6 | |
| SCHEMBL18978514 | 0.73 | HDAC8 (0.45) | HDAC8SLC22A1PRCPCYP3A4CYP2C19 | |
| SCHEMBL1317448 | 0.73 | CACNA1G (0.56) | HDAC8CACNA1GCYP3A4CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0879053-A1 | USE OF AN ANTAGONIST OF PPAR-ALPHA AND PPAR-GAMMA FOR THE TREATMENT OF SYNDROM X | SMITHKLINE BEECHAM PLC (GB) | 1998-11-25 | — | — | EP | disclosed |
| WO-1997025042-A1 | USE OF AN AGONIST OF PPAR-ALPHA AND PPAR-GAMMA FOR THE TREATMENT OF SYNDROM X | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-07-17 | — | — | WO | disclosed |
| WO-1996004261-A1 | BENZOXAZOLES AND PRYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES | SMITHKLINE BEECHAM PLC (GB) | 1996-02-15 | — | — | WO | disclosed |